Evidence map›Paper›PMID 26923837›Full record

ArticleNature communications2016

Hypothalamic leptin action is mediated by histone deacetylase 5.

Dhiraj G Kabra, Katrin Pfuhlmann, Cristina García-Cáceres, Sonja C Schriever, Veronica Casquero García, Adam Fiseha Kebede, Esther Fuente-Martin, Chitrang Trivedi, Kristy Heppner, N Henriette Uhlenhaut and 17 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed
4.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 87 citations in OpenAlex.

  1. Article
  2. The histone deacetylase family in health and disease.Signal transduction and targeted therapy · 2026
    Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Leptin signaling and leptin resistance.Medical review (2021) · 2022
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

27 authors at 6 institutions in 4 countries.

Dhiraj G KabraHelmholtz Diabetes Center, Helmholtz Zentrum München, 85764 Neuherberg, Germany.
Katrin PfuhlmannHelmholtz Diabetes Center, Helmholtz Zentrum München, 85764 Neuherberg, Germany.
Cristina García-CáceresHelmholtz Diabetes Center, Helmholtz Zentrum München, 85764 Neuherberg, Germany.
Sonja C SchrieverHelmholtz Diabetes Center, Helmholtz Zentrum München, 85764 Neuherberg, Germany.
Veronica Casquero GarcíaHelmholtz Diabetes Center, Helmholtz Zentrum München, 85764 Neuherberg, Germany.
Adam Fiseha KebedeInstitut de Génétique et de Biologie Moléculaire et Cellulaire, CNRS UMR 7104, INSERM U 964, Université de Strasbourg, Illkirch 67404, France.
Esther Fuente-MartinHelmholtz Diabetes Center, Helmholtz Zentrum München, 85764 Neuherberg, Germany.
Chitrang TrivediDepartment of Pharmacology &Toxicology, Zydus Research Centre, Cadila Healthcare Limited, Sarkhej-Bavla N.H. No. 8A, Moraiya, Ahmedabad 382210, India.
Kristy HeppnerMetabolic Diseases Institute, Division of Endocrinology, Department of Internal Medicine, University of Cincinnati, Cincinnati, Ohio 45237, USA.
N Henriette UhlenhautHelmholtz Diabetes Center, Helmholtz Zentrum München, 85764 Neuherberg, Germany.
Beata LegutkoHelmholtz Diabetes Center, Helmholtz Zentrum München, 85764 Neuherberg, Germany.
Uma D KabraHelmholtz Diabetes Center, Helmholtz Zentrum München, 85764 Neuherberg, Germany.
Yuanqing GaoHelmholtz Diabetes Center, Helmholtz Zentrum München, 85764 Neuherberg, Germany.
Chun-Xia YiHelmholtz Diabetes Center, Helmholtz Zentrum München, 85764 Neuherberg, Germany.
Carmelo QuartaHelmholtz Diabetes Center, Helmholtz Zentrum München, 85764 Neuherberg, Germany.
Christoffer ClemmensenHelmholtz Diabetes Center, Helmholtz Zentrum München, 85764 Neuherberg, Germany.
Brian FinanHelmholtz Diabetes Center, Helmholtz Zentrum München, 85764 Neuherberg, Germany.
Timo D MüllerHelmholtz Diabetes Center, Helmholtz Zentrum München, 85764 Neuherberg, Germany.
Carola W MeyerHelmholtz Diabetes Center, Helmholtz Zentrum München, 85764 Neuherberg, Germany.
Marcelo Paez-PeredaMax Planck Institute of Psychiatry, Kraepelinstr. 2-10, 80804 München, Germany.
Kerstin StemmerHelmholtz Diabetes Center, Helmholtz Zentrum München, 85764 Neuherberg, Germany.
Stephen C WoodsMetabolic Diseases Institute, Division of Endocrinology, Department of Internal Medicine, University of Cincinnati, Cincinnati, Ohio 45237, USA.
Diego Perez-TilveMetabolic Diseases Institute, Division of Endocrinology, Department of Internal Medicine, University of Cincinnati, Cincinnati, Ohio 45237, USA.
Robert SchneiderInstitut de Génétique et de Biologie Moléculaire et Cellulaire, CNRS UMR 7104, INSERM U 964, Université de Strasbourg, Illkirch 67404, France.
Eric N OlsonDepartment of Molecular Biology, UT Southwestern Medical Center, Dallas, Texas 75390, USA.
Matthias H TschöpHelmholtz Diabetes Center, Helmholtz Zentrum München, 85764 Neuherberg, Germany.
Paul T PflugerHelmholtz Diabetes Center, Helmholtz Zentrum München, 85764 Neuherberg, Germany.ORCID http://orcid.org/0000-0002-8118-7588
Helmholtz Zentrum München · DEUniversity of Cincinnati · USCentre National de la Recherche Scientifique · FRCadila Healthcare (India) · INMax Planck Institute of Psychiatry · DESouthwestern Medical Center · US

Funding

Transgenic CoreP30DK057521 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI FLOREZ, JOSE CARLOS · 2000 to 2019
$31.4M
Stem Cell/Organoid and Genome Editing CoreP30DK078392 · NIDDK · CINCINNATI CHILDRENS HOSP MED CTR · PI Alexander Miethke · 2007 to 2026
$24.4M
NIDDK NIH HHS P30 DK057521NIDDK NIH HHS P30 DK078392
6 · The paper itself

Abstract

Hypothalamic leptin signalling has a key role in food intake and energy-balance control and is often impaired in obese individuals. Here we identify histone deacetylase 5 (HDAC5) as a regulator of leptin signalling and organismal energy balance. Global HDAC5 KO mice have increased food intake and greater diet-induced obesity when fed high-fat diet. Pharmacological and genetic inhibition of HDAC5 activity in the mediobasal hypothalamus increases food intake and modulates pathways implicated in leptin signalling. We show HDAC5 directly regulates STAT3 localization and transcriptional activity via reciprocal STAT3 deacetylation at Lys685 and phosphorylation at Tyr705. In vivo, leptin sensitivity is substantially impaired in HDAC5 loss-of-function mice. Hypothalamic HDAC5 overexpression improves leptin action and partially protects against HFD-induced leptin resistance and obesity. Overall, our data suggest that hypothalamic HDAC5 activity is a regulator of leptin signalling that adapts food intake and body weight to our dietary environment.

Indexed as

AnimalsBlood GlucoseCell LineGene Expression RegulationGene Knockdown TechniquesGlucose Tolerance TestHistone DeacetylasesHypothalamusInfusions, IntraventricularInsulin ResistanceLaser Capture MicrodissectionLeptinMaleMelanocyte-Stimulating HormonesMiceMice, Inbred StrainsBlood GlucoseHdac5 protein, mouseHistone DeacetylasesLeptinMelanocyte-Stimulating HormonesSHU 9119

Identifiers

PMID26923837
PMCPMC4773494
OpenAlexW2297189398

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.